Global tuberculosis incidence has declined marginally over the past decade, and
tuberculosis remains out of control in several parts of the world including Africa and Asia …

Tuberculosis is one of the oldest diseases known to humankind and it is currently a
worldwide threat with 8–9 million new active disease being reported every year. Among …

Drug-resistant tuberculosis is a substantial health-care concern worldwide. Despite culture-
based methods being considered the gold standard for drug susceptibility testing, molecular …

Background Tuberculosis remains a major public-health problem in the world, despite
several efforts to improve case identification and treatment compliance. It is well known …

The emergence of drug-resistant strains of Mycobacterium tuberculosis is a challenge to
global tuberculosis (TB) control. Although culture-based methods have been regarded as …

Over 480 000 cases of multidrug-resistant (MDR) tuberculosis (TB) occur every year
globally, 9% of them being affected by extensively drug-resistant (XDR) strains of …

Background Multidrug resistant (MDR) tuberculosis (TB) represents TB which is
simultaneous resistant to at least rifampicin (R) and isoniazid (H). Identifying inadequate …

Multidrug-resistant tuberculosis (MDR-TB) in low-incidence countries in Europe is more
prevalent among migrants than the native population. The impact of the recent increase in …

The figures provided by the World Health Organization (WHO) in its 2013 global tuberculosis
(TB) report are remarkable; TB continues to represent a significant clinical and public health …

With increasing incidence of multidrug-resistant tuberculosis (MDR-TB), accurate drug
susceptibility testing (DST) of Mycobacterium tuberculosis to first-line drugs has become …